N Acetylcysteine - NutraPedia

Back to Table of Contents

N-Acetylcysteine (NAC) Overview

1. Studied Conditions

N-Acetylcysteine has been studied for various conditions, including:

  • Acetaminophen (Tylenol) poisoning
  • Chronic obstructive pulmonary disease (COPD)
  • Chronic bronchitis
  • Influenza
  • Cystic fibrosis
  • Psychiatric disorders, such as depression and bipolar disorder
  • Substance use disorders
  • Polycystic ovary syndrome (PCOS)

2. Efficacy in Treating Conditions

Studies have shown varying results:

  • It is a well-established treatment for acetaminophen poisoning when administered promptly.
  • It may provide some benefits in chronic respiratory conditions but results are mixed.
  • Its effectiveness in psychiatric disorders and substance use disorders is still under investigation.
  • For PCOS and fertility, some evidence suggests it may improve insulin sensitivity and ovulation rates.

3. Health Benefits

The health benefits of NAC may include:

  • Antioxidant effects
  • Mucolytic action, helping to break down mucus
  • Supporting liver health
  • Boosting glutathione levels, an important antioxidant produced by the body
  • Potentially reducing inflammation

4. Downsides

While NAC is generally considered safe, it has potential downsides, such as:

  • Gastrointestinal discomfort, including nausea and diarrhea
  • Rashes
  • Headaches
  • Rarely, it can cause more serious side effects like bronchospasm in people with asthma
  • Potential interactions with certain medications

5. Genetic Variations

Research on NAC's benefits or harms in relation to specific genetic variations is limited. However, some genetic factors may influence how individuals metabolize and respond to NAC. It is always recommended to consult a healthcare professional before starting any new supplement, especially if there is a known genetic condition or predisposition.

N-Acetylcysteine (NAC) in Medical Treatment

N-acetylcysteine (NAC) is a medication primarily used for acetaminophen poisoning and as a mucolytic to reduce mucus in the airways. It has a good safety profile, with rare toxicity linked to high doses or specific administration routes. NAC's antioxidant and anti-inflammatory properties may benefit diseases involving oxidative stress and inflammation.

NAC boosts glutathione levels, a key cellular antioxidant, and lowers pro-inflammatory molecules like TNF-α and interleukins. It's promising in experimental studies, but clinical effectiveness for various diseases is yet to be conclusively shown.

NAC may offer benefits for patients with cystic fibrosis (CF) due to its antioxidant activity and potential to prevent and eliminate biofilms, especially against Pseudomonas aeruginosa.

Beyond its established uses, NAC could potentially aid in treating a wide array of conditions including polycystic ovary syndrome, male infertility, sleep apnea, AIDS, influenza, Parkinson's, multiple sclerosis, neuropathies, stroke outcomes, Crohn's disease, ulcerative colitis, schizophrenia, bipolar disorder, and obsessive-compulsive disorder. It may also act as a chelator for heavy metals.

In vitro studies suggest NAC's effectiveness in breaking down mucoproteins, aiding in respiratory therapy for conditions with mucus accumulation.

NAC's role in managing oxidative stress in diseases like atherosclerosis, Alzheimer's, and cancer is highlighted, although clinical trials have not always yielded expected results.

NAC's protective role often involves neutralizing harmful substances or their byproducts, like those from metabolism or lipid peroxidation. The complexity of oxidative stress and its connection to cellular processes like fatigue during intense exercise is emphasized.

Clinical studies have shown NAC's effectiveness in improving clinical symptoms and lung function in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and in reducing the frequency of exacerbations in chronic bronchitis and COPD.

Moreover, NAC has been found to significantly reduce certain markers of inflammation and oxidative stress in controlled clinical trials.

Despite potential applications in psychiatric conditions and neurotoxicity prevention, the clinical efficacy of NAC for these disorders requires further investigation. Additionally, NAC may protect against heavy metal-induced kidney damage and restore antioxidant levels in lead-exposed workers.

NAC supplementation showed a significant reduction in total testosterone levels and increased FSH levels in women with polycystic ovary syndrome (PCOS), potentially improving reproductive function.

However, some studies caution against the use of antioxidants like NAC in cancer treatment as they may promote tumor growth and reduce the effectiveness of anti-cancer drugs by lowering ROS levels.

References:


  1. N-Acetylcysteine (NAC): Impacts on Human Health
  2. N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review
  3. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks)
  4. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine
  5. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
  6. Quantitative nutritional studies with water-soluble, chemically defined diets. III. Individual amino acids as sources of non-essential nitrogen
  7. Long-term neurobehavioral and histological damage in brain of mice induced by L-cysteine
  8. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress
  9. Treatment of abdominal pain in cystic fibrosis by oral administration of n-acetyl cysteine
  10. Acetylcysteine for acetaminophen poisoning
  11. Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease
  12. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
  13. The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review
  14. Effect of Orally Administered N-Acetylcysteine on Chronic Bronchitis: A Meta-analysis
  15. The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis
  16. N-Acetylcysteine: Antioxidant, Aldehyde Scavenger, and More
  17. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
  18. N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases
  19. The effects of N-acetylcysteine on inflammatory and oxidative stress biomarkers: A systematic review and meta-analysis of controlled clinical trials
  20. N-acetylcysteine as a new prominent approach for treating psychiatric disorders
  21. Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats
  22. The administration of N-acetylcysteine reduces oxidative stress and regulates glutathione metabolism in the blood cells of workers exposed to lead
  23. Glutathione, glutathione-related enzymes, and oxidative stress in individuals with subacute occupational exposure to lead
  24. Modulation by N-acetylcysteine of lead-induced alterations in rat brain: reduced glutathione levels and morphology
  25. In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine
  26. The effects of N-acetylcysteine on ovulation and sex hormones profile in women with polycystic ovary syndrome: a systematic review and meta-analysis
  27. Comparison of the efficacy between NAC and metformin in treating PCOS patients: a meta-analysis
  28. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
  29. The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis
  30. N-acetylcysteine for schizophrenia: A systematic review and meta-analysis
  31. Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia
  32. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
  33. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis
  34. Effectiveness of N-acetylcysteine in autism spectrum disorders: A meta-analysis of randomized controlled trials
  35. N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis
  36. Free radicals and muscle fatigue: Of ROS, canaries, and the IOC
  37. Effect of N-acetylcysteine on diaphragm fatigue
  38. Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro
  39. Performance and Side Effects of Supplementation with N-Acetylcysteine: A Systematic Review and Meta-Analysis
  40. N-Acetylcysteine's attenuation of fatigue after repeated bouts of intermittent exercise: practical implications for tournament situations
  41. Effect of N-acetylcysteine on cycling performance after intensified training
  42. N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals
  43. Infusion with the antioxidant N-acetylcysteine attenuates early adaptive responses to exercise in human skeletal muscle
  44. Acetaminophen Toxicity
  45. N-acetylcysteine overdose after acetaminophen poisoning
  46. Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer
  47. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer
  48. The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice
  49. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
  50. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
  51. Antioxidants can increase melanoma metastasis in mice
  52. Antioxidants accelerate lung cancer progression in mice
  53. Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1
  54. Genotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants
  55. Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
  56. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial
  57. GlyNAC (Glycine and N-Acetylcysteine) Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study
  58. GlyNAC Supplementation Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Aging Hallmarks, Metabolic Defects, Muscle Strength, Cognitive Decline, and Body Composition: Implications for Healthy Aging
  59. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
  60. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine
  61. Successful treatment of acetaminophen overdose associated with hepatic failure
  62. Use of N-Acetylcysteine in Amphetamine-Induced Acute Liver Failure
  63. N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial
  64. Mitochondrial modulators for obsessive-compulsive and related disorders: a systematic review and meta-analysis
  65. The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and N-acetylcysteine Are the Preventers
  66. Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients
  67. N-acetyl cysteine as a potential regulator of SARS-CoV-2-induced male reproductive disruptions
  68. N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies
  69. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks)
  70. A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage
  71. Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
  72. Paracetamol overdose: the liver unit perspective
  73. Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity
  74. Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration
  75. L-NAC reverses of the adverse effects of fentanyl infusion on ventilation and blood-gas chemistry
  76. N-acetylcysteine as a new prominent approach for treating psychiatric disorders
  77. Successful use of N-acetylcysteine to treat severe hepatic injury caused by a dietary fitness supplement
  78. N-acetylcysteine as a treatment for amatoxin poisoning: a systematic review
  79. Medical and Dietary Uses of N-Acetylcysteine
  80. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis
  81. Subchronic N-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice
  82. GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Mice Increases Length of Life by Correcting Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Abnormalities in Mitophagy and Nutrient Sensing, and Genomic Damage
  83. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits
  84. N-Acetylcysteine Mitigates Social Dysfunction in a Rat Model of Autism Normalizing Glutathione Imbalance and the Altered Expression of Genes Related to Synaptic Function in Specific Brain Areas
  85. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine
  86. Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice
  87. A minireview on N-acetylcysteine: An old drug with new approaches
  88. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial
  89. Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats
  90. Role of kynurenines in the central and peripheral nervous systems
  91. Iron, Neuroinflammation and Neurodegeneration
  92. Dramatic Improvement of Trichotillomania with 6 Months of Treatment With N-Acetylcysteine
  93. N-Acetylcysteine (NAC): Impacts on Human Health
  94. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
  95. Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass
  96. The Roles of Antidotes in Emergency Situations
  97. N-Acetylcysteine Inhibits Kynurenine Aminotransferase II
  98. Paracetamol self-poisoning: when oral N-acetylcysteine saves life? a case report
  99. The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione
  100. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study
  101. Oxidative Stress in Chronic Obstructive Pulmonary Disease
  102. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
  103. Late extensive intravenous administration of N-acetylcysteine can reverse hepatic failure in acetaminophen overdose


Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!